187 related articles for article (PubMed ID: 29441977)
1. Production and
Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
[TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
3. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
4. Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion.
Patel GC; Kasarwala M
Recent Pat Drug Deliv Formul; 2016; 10(3):222-234. PubMed ID: 27712567
[TBL] [Abstract][Full Text] [Related]
5. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
Banerjee A; Verma PR; Gore S
AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
[TBL] [Abstract][Full Text] [Related]
6. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
Yakubu R; Peh KK; Tan YT
Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
[TBL] [Abstract][Full Text] [Related]
7. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
Liu L; Xu X
Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
Cheng X; Sun M; Gao Y; Cao F; Zhai G
Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
[TBL] [Abstract][Full Text] [Related]
9. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
Liu L; Wang J; Zhu S
Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
[TBL] [Abstract][Full Text] [Related]
10. [The delivery mechanism of micro-porous osmotic pump tablets].
Zhao XL; Li Q; Gong XF; Li SM
Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
[TBL] [Abstract][Full Text] [Related]
11. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation.
Emara LH; Taha NF; El-Ashmawy AA; Raslan HM; Mursi NM
Pharm Dev Technol; 2014 Sep; 19(6):681-91. PubMed ID: 24320694
[TBL] [Abstract][Full Text] [Related]
12. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
13. [Studies on preparation and dissolution test in vitro of intragastric floating two-chamber osmotic pump tablets of total alkaloids of Coptis chinensis and Evodia rutaecarpa].
Fang Y; Shi QW
Zhong Yao Cai; 2011 May; 34(5):779-82. PubMed ID: 21954566
[TBL] [Abstract][Full Text] [Related]
14. Aqueous Polymer Dispersion Coating Used for Osmotic Pump Tablets: Membrane Property Investigation and IVIVC Evaluation.
Cheng L; Gai X; Wen H; Liu D; Tang X; Wang Y; Wang T; Pan W; Yang X
AAPS PharmSciTech; 2018 Jan; 19(1):242-250. PubMed ID: 28695327
[TBL] [Abstract][Full Text] [Related]
15. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach.
Gundu R; Pekamwar S; Shelke S; Shep S; Kulkarni D
Drug Dev Ind Pharm; 2020 Mar; 46(3):343-355. PubMed ID: 31937128
[TBL] [Abstract][Full Text] [Related]
16. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
17. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
18. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
[TBL] [Abstract][Full Text] [Related]
19. [Unitary-core osmotic pump tablet for controlled release of water-insoluble drug].
Liu LX; Xu Q; Khang G; Rhee JM; Lee HB
Yao Xue Xue Bao; 2003 Dec; 38(12):966-7. PubMed ID: 15040097
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
